Engineered E. coli that detect and respond to gut inflammation through nitric oxide sensing.

Advances in synthetic biology now allow for the reprogramming of microorganisms to execute specific tasks. Here, we describe the development of an engineered strain of E. coli capable of sensing and responding to the presence of a mammalian inflammatory signal. The synthetic gene regulatory circuit is designed to permanently alter gene expression in response to the well characterized inflammatory signal nitric oxide. The detection of nitric oxide initiates the expression of a DNA recombinase, causing the permanent activation of a DNA switch. We demonstrate that E. coli containing this synthetic circuit respond to nitric oxide from both chemical and biological sources, with permanent DNA recombination occurring in the presence of nitric oxide donor compounds or inflamed mouse ileum explants. In the future, this synthetic genetic circuit will be optimized to allow E. coli to reliably detect and respond to inflammation in vivo.

[1]  Nathan J Hillson,et al.  j5 DNA assembly design automation software. , 2012, ACS synthetic biology.

[2]  A. Bookout,et al.  Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways , 2003, Nuclear receptor signaling.

[3]  Ken Kleinman,et al.  The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  H. Neumann,et al.  Synthetic biology approaches in drug discovery and pharmaceutical biotechnology , 2010, Applied Microbiology and Biotechnology.

[5]  J. Rioux,et al.  ATG16L1 and IL23R Are Associated With Inflammatory Bowel Diseases but Not With Celiac Disease in The Netherlands , 2008, The American Journal of Gastroenterology.

[6]  M. S. McClain,et al.  Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli , 1991, Journal of bacteriology.

[7]  S. Kliewer,et al.  Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D* , 2010, The Journal of Biological Chemistry.

[8]  Dan Ferber,et al.  Microbes Made to Order , 2004, Science.

[9]  Timothy S. Ham,et al.  Metabolic engineering of microorganisms for biofuels production: from bugs to synthetic biology to fuels. , 2008, Current opinion in biotechnology.

[10]  Markus Wieland,et al.  Engineering molecular circuits using synthetic biology in mammalian cells. , 2012, Annual review of chemical and biomolecular engineering.

[11]  P. Savelkoul,et al.  The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and Probiotics , 2001, Scandinavian journal of gastroenterology. Supplement.

[12]  M. Elowitz,et al.  Reconstruction of genetic circuits , 2005, Nature.

[13]  J. Monod,et al.  Genetic regulatory mechanisms in the synthesis of proteins. , 1961, Journal of molecular biology.

[14]  Judy H. Cho,et al.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.

[15]  Pamela A Silver,et al.  Harnessing nature's toolbox: regulatory elements for synthetic biology , 2009, Journal of The Royal Society Interface.

[16]  Loren L Looger,et al.  Computational design of receptors for an organophosphate surrogate of the nerve agent soman. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Marvin,et al.  Conversion of a maltose receptor into a zinc biosensor by computational design , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  James C. W. Locke,et al.  Stochastic Pulse Regulation in Bacterial Stress Response , 2011, Science.

[19]  W. Fiers,et al.  Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. , 2000, Science.

[20]  Christopher A. Voigt,et al.  A Synthetic Genetic Edge Detection Program , 2009, Cell.

[21]  R. Xavier,et al.  Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine , 2010, Cell.

[22]  W. Szybalski,et al.  Expression plasmid with a very tight two-step control: Int/att-mediated gene inversion with respect to the stationary promoter. , 2001, Gene.

[23]  Christopher A. Voigt,et al.  Genetic parts to program bacteria. , 2006, Current opinion in biotechnology.

[24]  Jeremy Minshull,et al.  Engineering the Salmonella type III secretion system to export spider silk monomers , 2009, Molecular systems biology.

[25]  R. Gearry,et al.  Review article: appropriate use of corticosteroids in Crohn’s disease , 2007, Alimentary pharmacology & therapeutics.

[26]  Wei-Guo Zhu,et al.  Surf the Post-translational Modification Network of p53 Regulation , 2012, International journal of biological sciences.

[27]  Shankar Mukherji,et al.  Synthetic biology: understanding biological design from synthetic circuits , 2009, Nature Reviews Genetics.

[28]  N. Tucker,et al.  Transcriptional regulation by the dedicated nitric oxide sensor, NorR: a route towards NO detoxification. , 2011, Biochemical Society transactions.

[29]  Christopher A. Voigt,et al.  Environmentally controlled invasion of cancer cells by engineered bacteria. , 2006, Journal of molecular biology.

[30]  Chueh Loo Poh,et al.  Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen , 2011, Molecular systems biology.

[31]  Philip Ball,et al.  Synthetic biology for nanotechnology , 2004 .

[32]  M. Stolte,et al.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine , 2004, Gut.

[33]  E. Andrianantoandro,et al.  Synthetic biology: new engineering rules for an emerging discipline , 2006, Molecular systems biology.

[34]  N. Tucker,et al.  Analysis of the Nitric Oxide-sensing Non-heme Iron Center in the NorR Regulatory Protein* , 2008, Journal of Biological Chemistry.

[35]  S. Hanauer,et al.  Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities , 2006, Inflammatory bowel diseases.

[36]  R Balfour Sartor,et al.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.

[37]  I. Talbot,et al.  Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment. , 1998, Journal of clinical pathology.

[38]  P. Swain,et al.  Stochastic Gene Expression in a Single Cell , 2002, Science.

[39]  R. Caprilli,et al.  Recent advances in the management of Crohn's disease. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[40]  Rajan P Kulkarni,et al.  Tunability and Noise Dependence in Differentiation Dynamics , 2007, Science.

[41]  Timothy S. Ham,et al.  Design and Construction of a Double Inversion Recombination Switch for Heritable Sequential Genetic Memory , 2008, PloS one.

[42]  Jay D Keasling,et al.  Metabolic engineering of microbial pathways for advanced biofuels production. , 2011, Current opinion in biotechnology.

[43]  J. March,et al.  Secretion of Insulinotropic Proteins by Commensal Bacteria: Rewiring the Gut To Treat Diabetes , 2008, Applied and Environmental Microbiology.

[44]  P. Swain,et al.  Accurate prediction of gene feedback circuit behavior from component properties , 2007, Molecular systems biology.

[45]  Christopher A. Voigt,et al.  Synthetic biology: Engineering Escherichia coli to see light , 2005, Nature.

[46]  D. E. Benson,et al.  Converting a maltose receptor into a nascent binuclear copper oxygenase by computational design. , 2002, Biochemistry.

[47]  Timothy B. Stockwell,et al.  Complete Chemical Synthesis, Assembly, and Cloning of a Mycoplasma genitalium Genome , 2008, Science.

[48]  Ron Weiss,et al.  Design and connection of robust genetic circuits. , 2011, Methods in enzymology.

[49]  Timothy S. Ham,et al.  A tightly regulated inducible expression system utilizing the fim inversion recombination switch. , 2006, Biotechnology and bioengineering.

[50]  B. Coulie,et al.  Actobiotics™ as a Novel Method for Cytokine Delivery , 2009, Annals of the New York Academy of Sciences.

[51]  David J. Studholme,et al.  DNA Binding Activity of the Escherichia coli Nitric Oxide Sensor NorR Suggests a Conserved Target Sequence in Diverse Proteobacteria , 2004, Journal of bacteriology.

[52]  Christopher A. Voigt,et al.  Automated Design of Synthetic Ribosome Binding Sites to Precisely Control Protein Expression , 2009, Nature Biotechnology.

[53]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[54]  P. T. Schmidt,et al.  Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders. , 2006, World journal of gastroenterology.

[55]  C. Lees,et al.  Guidelines for the management of inflammatory bowel disease in adults , 2011, Gut.

[56]  D. Hommes,et al.  High frequency of early colorectal cancer in inflammatory bowel disease , 2008, Gut.

[57]  Inna Dubchak,et al.  Dissimilatory Metabolism of Nitrogen Oxides in Bacteria: Comparative Reconstruction of Transcriptional Networks , 2005, PLoS Comput. Biol..

[58]  G. Jevon,et al.  Endoscopic and histologic findings in pediatric inflammatory bowel disease. , 2010, Gastroenterology & hepatology.

[59]  J. Collins,et al.  DIVERSITY-BASED, MODEL-GUIDED CONSTRUCTION OF SYNTHETIC GENE NETWORKS WITH PREDICTED FUNCTIONS , 2009, Nature Biotechnology.

[60]  M. Elowitz,et al.  Build life to understand it , 2010, Nature.

[61]  S. Basu,et al.  A synthetic multicellular system for programmed pattern formation , 2005, Nature.

[62]  R. Baldassano,et al.  Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients , 2010, Inflammatory bowel diseases.

[63]  Gürol M. Süel,et al.  Use of fluorescence microscopy to analyze genetic circuit dynamics. , 2011, Methods in enzymology.

[64]  Peter Hänggi,et al.  Stochastic resonance in biology. How noise can enhance detection of weak signals and help improve biological information processing. , 2002, Chemphyschem : a European journal of chemical physics and physical chemistry.

[65]  M. Sans,et al.  Inflammatory bowel disease: the role of environmental factors. , 2004, Autoimmunity reviews.

[66]  J. Keasling,et al.  Microbial production of fatty-acid-derived fuels and chemicals from plant biomass , 2010, Nature.

[67]  Jonathan A. Goler,et al.  Chemical synthesis using synthetic biology. , 2009, Current opinion in biotechnology.

[68]  P. Hellström,et al.  Rectal nitric oxide assessment in children with Crohn disease and ulcerative colitis. Indicator of ileocaecal and colorectal affection. , 2001, Scandinavian journal of gastroenterology.

[69]  M. Elowitz,et al.  Synthetic Biology: Integrated Gene Circuits , 2011, Science.

[70]  M. Hutchings,et al.  The NorR Protein of Escherichia coli Activates Expression of the Flavorubredoxin Gene norV in Response to Reactive Nitrogen Species , 2002, Journal of bacteriology.

[71]  S. Mangan,et al.  Structure and function of the feed-forward loop network motif , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[72]  K. Prather,et al.  De novo biosynthetic pathways: rational design of microbial chemical factories. , 2008, Current opinion in biotechnology.

[73]  Jeff Hasty,et al.  Genetic Circuits in Salmonella typhimurium , 2012, ACS synthetic biology.

[74]  P. R. Gardner,et al.  Regulation of the Nitric Oxide Reduction Operon (norRVW) inEscherichia coli: ROLE OF NorR AND ς54IN THE NITRIC OXIDE STRESS RESPONSE , 2003 .

[75]  W. Tremaine,et al.  American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. , 2006, Gastroenterology.

[76]  Petra Schwille,et al.  Synthetic biology of minimal systems , 2009, Critical reviews in biochemistry and molecular biology.

[77]  N. Tucker,et al.  Mechanism of transcriptional regulation by the Escherichia coli nitric oxide sensor NorR. , 2006, Biochemical Society transactions.

[78]  H. Ishii,et al.  Increased Nitric Oxide Production and Inducible Nitric Oxide Synthase Activity in Colonic Mucosa of Patients with Active Ulcerative Colitis and Crohn's Disease , 1997, Digestive Diseases and Sciences.

[79]  H. Olsson,et al.  Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas , 2005, Annals of the rheumatic diseases.

[80]  N. Tucker,et al.  Nitric oxide-responsive interdomain regulation targets the σ54-interaction surface in the enhancer binding protein NorR , 2010, Molecular microbiology.

[81]  P. Klemm,et al.  Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. , 1986, The EMBO journal.

[82]  Raymond A Zilinskas,et al.  The promise and perils of synthetic biology. , 2006, New Atlantis.

[83]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[84]  Sylvie Chevalier,et al.  Gram-Negative Bacterial Sensors for Eukaryotic Signal Molecules , 2009, Sensors.

[85]  Alan Villalobos,et al.  Gene Designer: a synthetic biology tool for constructing artificial DNA segments , 2006, BMC Bioinformatics.

[86]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[87]  Jeff Hasty,et al.  Engineered gene circuits , 2002, Nature.

[88]  N. Tucker,et al.  Essential roles of three enhancer sites in σ54-dependent transcription by the nitric oxide sensing regulatory protein NorR , 2009, Nucleic acids research.

[89]  V. Gross,et al.  Etiology and pathophysiology of inflammatory bowel disease--environmental factors. , 2000, Hepato-gastroenterology.

[90]  Gürol M. Süel,et al.  Biological role of noise encoded in a genetic network motif , 2010, Proceedings of the National Academy of Sciences.

[91]  Martin Fussenegger,et al.  Mammalian synthetic biology – from tools to therapies , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.

[92]  S. Shen-Orr,et al.  Network motifs: simple building blocks of complex networks. , 2002, Science.

[93]  J. Dolan,et al.  Use of Genetically Engineered Phage To Deliver Antimicrobial Agents to Bacteria: an Alternative Therapy for Treatment of Bacterial Infections , 2003, Antimicrobial Agents and Chemotherapy.

[94]  I. Blomfield,et al.  Comparative analysis of FimB and FimE recombinase activity. , 2007, Microbiology.

[95]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[96]  P. Lambin,et al.  Clostridium spores for tumor-specific drug delivery. , 2002, Anti-cancer drugs.

[97]  L. Tsimring,et al.  A synchronized quorum of genetic clocks , 2009, Nature.

[98]  Michael B. Elowitz,et al.  Architecture-Dependent Noise Discriminates Functionally Analogous Differentiation Circuits , 2009, Cell.

[99]  O. Griffith,et al.  Design of isoform-selective inhibitors of nitric oxide synthase. , 1998, Current opinion in chemical biology.

[100]  Wendell A Lim,et al.  Synthetic biology: lessons from the history of synthetic organic chemistry , 2007, Nature Chemical Biology.

[101]  L. Looger,et al.  Computational design of receptor and sensor proteins with novel functions , 2003, Nature.

[102]  Christopher A. Voigt,et al.  Environmental signal integration by a modular AND gate , 2007, Molecular systems biology.

[103]  J. Collins,et al.  Construction of a genetic toggle switch in Escherichia coli , 2000, Nature.

[104]  A. Piccin,et al.  Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia , 2010, American journal of hematology.

[105]  Víctor de Lorenzo,et al.  Systems biology approaches to bioremediation. , 2008 .

[106]  M. Elowitz,et al.  A synthetic oscillatory network of transcriptional regulators , 2000, Nature.

[107]  Karl D. Brune,et al.  Engineering microbial consortia to enhance biomining and bioremediation , 2012, Front. Microbio..

[108]  G. Storey,et al.  Beclomethasone Dipropionate: A New Steroid Aerosol for the Treatment of Allergic Asthma , 1972, British medical journal.

[109]  D. Belin,et al.  Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter , 1995, Journal of bacteriology.

[110]  E. Remaut,et al.  Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis , 2010, Mucosal Immunology.

[111]  Christopher A. Voigt,et al.  Robust multicellular computing using genetically encoded NOR gates and chemical ‘wires’ , 2011, Nature.

[112]  E. Loftus Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. , 2004, Gastroenterology.

[113]  John C March,et al.  Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model , 2010, Proceedings of the National Academy of Sciences.